Lilly is counting on next-generation incretin medicines like Retatrutideas well as its oral GLP-1 Orforglipronto eventually pick up the torch from its current diabetes and obesity mainstays Mounjaro and Zepbound, both of which are underpinned by Lillys dual GIP/GLP-1 receptor agonist Tirzepatide
What "oral tirzepatide" products actually are today Any product currently marketed as "oral tirzepatide" falls into one of these categories: Remaining compounded inventory
The great thing is being able to cook your own meals, so you know exactually what is going into them
Penn study focuses on semaglutide and mental health impacts An analysis of over 3,500 participants in clinical trials found no increased risk of mental health issues among those using the weight loss medication
From a theoretical neurobiological perspective, GLP-1 receptors are present throughout the central nervous system, including regions involved in emotional regulation such as the hypothalamus, amygdala, and prefrontal cortex